QD Quadramed Corp.

QuadraMed(R) Corporation (Amex:QD) today announced that the company has released QuadraMed TempusOne(R) v8.2 for general availability. QuadraMed TempusOne is a leading multi-facility, conflict-checking, enterprise scheduling and integrated Access Management product, enabling healthcare organizations to avoid or correct wasteful steps in the revenue cycle caused by incomplete, erroneous or non-accessible patient data. QuadraMed TempusOne v8.2, the first of three planned product enhancements for TempusOne expected to be released in 2006, incorporates advanced functionality in two critical areas. The first integrates TempusOne Physician Web Scheduler with electronic physician orders generation so that as an appointment is being scheduled, the physician can simultaneously generate the signed electronic orders required for treatment. These orders are stored, maintained and retrievable within the QuadraMed TempusOne database. Adding this electronic order functionality at the time of physician scheduling promotes a paperless environment and adds the assurance of an order on-hand at the hospital, increasing efficiency, lowering healthcare costs, and most importantly, improving patient safety. This latest, enhanced version also includes the first phase of an electronic worklist. The "worklist browser" facilitates the flow of additional user-defined appointment needs downstream within the healthcare enterprise enabling each department across the enterprise to know which additional services are needed for every patient, thereby streamlining care processes and improving patient satisfaction. QuadraMed TempusOne manages the scheduling and Access Management needs found in complex healthcare environments - large and multi-facility organizations, as well as Integrated Delivery Networks (IDNs). The software automatically checks conflicts at the patient, resource and physician levels, provides over 60 user-definable rules sets, integrates Access Management processes, conducts real time medical necessity checking, enables physician Web-scheduling and even features call-back reminders for patients. The secure, HL7 environment ensures seamless integration. New releases of QuadraMed TempusOne, as with v8.2, are typically client-installed in a matter of one hour or less with no interruption of existing service. Version 8.2 ships to existing clients immediately. Enterprise Scheduling and Access Management are integral parts of the QuadraMed Care-Based Revenue Cycle(TM) process, which helps hospitals to advance their financial success by leveraging quality care into positive financial outcomes. This QuadraMed strategic process also provides for interoperability for the connected healthcare community and quality measurement. For information about all QuadraMed products and services, visit www.quadramed.com or call 800-393-0278. About QuadraMed Corporation QuadraMed Corporation advances the success of healthcare organizations through IT solutions that leverage quality care into positive financial outcomes. As evolving reimbursement scenarios challenge healthcare organizations to leverage quality of care into payment, clients committing to QuadraMed's care-based solutions can realize market leading financial performance. Using QuadraMed's end-to-end solutions to optimize the patient experience and leverage quality of care into payment, our clients can receive the proper reimbursement, in the shortest time, at the lowest administrative cost. Behind our products and services is a staff of almost 600 professionals whose experience and dedication to service have earned QuadraMed the trust and loyalty of customers at approximately 2,000 healthcare provider facilities. To find out more about QuadraMed, visit www.quadramed.com. Cautionary Statement on Risks Associated with QuadraMed's Forward-Looking Statements This press release contains forward-looking statements, as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, by QuadraMed that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed's actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed's SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC's EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed and TempusOne are registered trademarks of QuadraMed Corporation. Care-Based Revenue Cycle is a trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.